Introduction:
The prognostic burden of inflammation in chronic kidney disease (CKD) remains poorly characterized, with prior small-scale studies yielding conflicting estimates of the association between elevated C-reactive protein (CRP) and cardio-renal outcomes.
Methods:
We conducted an observational study of...
Katherine R. Tuttle, F. Mazhar, Minjung Han et al.· Circulation· 0 citations
BACKGROUND AND AIMS
Hypertension is a common attributable cause of chronic kidney disease (CKD). Mineralocorticoid receptor overactivation can lead to hypertension and contributes to CKD progression. In FIND-CKD, finerenone reduced kidney function decline in participants with CKD without diabetes. This prespecified FIN...
H. Heerspink, Jelle M. Beernink, R. Agarwal et al.· European Heart Journal· 0 citations
BACKGROUND AND HYPOTHESIS
The burden and prognostic significance of inflammation in chronic kidney disease (CKD) remains poorly characterized, with prior studies yielding conflicting estimates of the association between elevated high-sensitivity C-reactive protein (hsCRP) and cardio-kidney outcomes.
METHODS
Observati...
F. Mazhar, Minjung Han, Katherine R. Tuttle et al.· Nephrology, Dialysis and Tra...· 0 citations
Although lower than PREVENT, KFRE showed moderate discrimination for CV disease prediction, offering dual kidney and CV risk stratification with a single simple tool.
Simon Correa, V. Castro, I. Beldhuis et al.· Kidney360· 0 citations
KEY POINTS
The cardiovascular-kidney-metabolic (CKM) syndrome framework has important implications in the care of people with kidney diseases. Cardiovascular screening is important in people with kidney diseases, but the approach may differ in this high-risk population. Multiple pharmacotherapies for CKM syndrome offer...
N. Bansal, P. Bjornstad, A. Bress et al.· Journal of the American Soci...· 3 citations
Heart failure (HF) remains a major cause of morbidity, mortality, and increased healthcare costs worldwide, and is recognized as the result of progressive cardiovascular-kidney-metabolic (CKM) syndrome. Obesity, type 2 diabetes, chronic kidney disease, hypertension, and atherosclerotic cardiovascular disease frequently...
R. Inciardi, A. Abdin, M. Abdelhamid et al.· European Journal of Heart Fa...· 0 citations
Investigating treatments for CKD possess anti-inflammatory properties that might contribute to their previously established clinical benefits, including renin-angiotensin-aldosterone system inhibitors, sodium-glucose cotransporter-2 inhibitors, glucagon-like peptide-1 receptor agonists and non-steroidal mineralocortico...
Katherine R. Tuttle, Mehmet Kanbay, Radica Z. Alicic et al.· Nature Reviews Nephrology· 1 citation
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.